Sign in to view content

The OASIS Trial: Efficacy and Safety Outcomes in Subjects With Full-Thickness Macular Hole

Michael Tolentino, MD

Video
Published 2016

Related

Treatment Response to Antioxidant Supplementation Based on CFH and ARMS2Â Genetic Risk Allele Number in AREDS Patients With No AMD at Baseline
Carl C. Awh, MD, FASRS
Annual Meeting Talks
2016
Vision Loss in a Patient With Primary Pulmonary Hypertension and Long-Term Use of Sildenafil
Christina Y Weng, MD, MBA, FASRS
Annual Meeting Talks
2016
Founders Award, Innovations in Retina Tumors 2016
Carol L. Shields, MD
Annual Meeting Talks
2016

Category: Macular Holes

See more